| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 3.842 | 20.755 | 98.405 | 197.740 | 154.286 | 147.752 | 169.806 | 170.029 |
| Total Income - EUR | - | - | 3.842 | 20.755 | 98.405 | 201.616 | 154.286 | 147.752 | 170.072 | 170.053 |
| Total Expenses - EUR | - | - | 1.503 | 990 | 50.024 | 103.197 | 38.472 | 48.153 | 51.686 | 95.804 |
| Gross Profit/Loss - EUR | - | - | 2.339 | 19.766 | 48.382 | 98.419 | 115.814 | 99.599 | 118.387 | 74.249 |
| Net Profit/Loss - EUR | - | - | 2.224 | 19.143 | 47.397 | 96.485 | 114.240 | 98.151 | 116.720 | 62.576 |
| Employees | - | - | 0 | 0 | 3 | 6 | 5 | 4 | 4 | 4 |
Check the financial reports for the company - Cardiosense Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 22.665 | 25.770 | 41.742 | 41.615 | 41.383 |
| Current Assets | - | - | 2.410 | 20.011 | 68.328 | 103.802 | 91.357 | 148.139 | 143.022 | 88.890 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 531 | 4.626 | 45.426 | 52.976 | 50.941 | 89.831 | 86.396 | 28.210 |
| Cash | - | - | 1.878 | 15.385 | 22.902 | 50.827 | 40.416 | 58.308 | 56.626 | 60.680 |
| Shareholders Funds | - | - | 2.267 | 19.195 | 47.448 | 96.576 | 114.337 | 98.248 | 116.817 | 62.673 |
| Social Capital | - | - | 44 | 43 | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | 142 | 816 | 20.880 | 29.891 | 2.790 | 91.633 | 67.821 | 67.600 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cardiosense Srl